Trending: Caribou Biosciences Scores Pfizer Investment
07 July 2023 - 12:44AM
Dow Jones News
10:14 ET -- Caribou Biosciences is one of the most mentioned
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. The clinical-stage biopharmaceutical
company received a $25 million equity investment from drug giant
Pfizer at a 31% premium, sending its shares up nearly 60%. Dow
Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
July 06, 2023 10:29 ET (14:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
From May 2024 to Jun 2024
Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
From Jun 2023 to Jun 2024